Newsfeeds Archive - Page 115 of 696

1 minute read

Omniq Receives A $1.2M Order From A Major Industrial Commercial And Residential Manufacturer

Yesterday, 8:32 AM

OMNIQ Corp.(NASDAQ:OMQS) ("OMNIQ" or the "Company"), a provider of Artificial Intelligence (AI)-based solutions, announced today that it has received a $1.2 million order from a major

OMQS

4 minute read

American Resources Corporation Names Tarlis Thompson As CEO Of American Carbon’s Mining Division

By Happy Mohamed

Yesterday, 8:31 AM

Tarlis Thompson has moved up in the ranks since joining the Company in 2015 and has demonstrated exemplary leadership and compassion while positioning and growing the carbon platform FISHERS, IN / ACCESSWIRE / August

AREC

2 minute read

Biotricity Shows Continued Growth And Strength In Its Fundamentals On Its Path To Profitability; Sees Record Q1-FY2024 Recurring Revenue Growth

By Happy Mohamed

Yesterday, 8:29 AM

Company to report robust performance improvements in its operating metrics Record Q1-FY2024 recurring revenue growth Significantly higher margins on technology fees compared to blended margins Strong control

BTCY

1 minute read

Esperion Therapeutics Announces Two CLEAR Outcomes Study Late-Breakers Accepted At European Society Of Cardiology Congress 2023

By Happy Mohamed

Yesterday, 8:08 AM

Esperion (NASDAQ:ESPR) today announced two oral presentations to take place in the Late-Breaking Science Session entitled "Clinical trial updates on prevention and lipid lowering" at the 2023 ESC Congress

ESPR

4 minute read

Verrica Pharmaceuticals Announces Presentation Of Lesion Clearance Data From An Ongoing Phase 2 Study Of VP-315 For The Treatment Of Basal Cell Carcinoma At The American Academy Of Dermatology 2023 Innovation Academy Meeting

By Happy Mohamed

August 10, 5:22 PM

Presentation highlights the antitumor response of VP-315 for the non-surgical treatment of Basal Cell Carcinoma (BCC) as determined by clinical and histological lesion clearance There are approximately 3-4

VRCA

1 minute read

News

Bluejay Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement

By Happy Mohamed

August 10, 5:19 PM

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care

BJDX

2 minute read

Adverum Biotechnologies Completes Enrollment Of Phase 2 LUNA Trial In Wet AMD

By Happy Mohamed

August 10, 5:11 PM

- LUNA 14-week data on aflibercept protein levels anticipated in the third quarter of 2023 and preliminary efficacy and safety data anticipated in the fourth quarter of 2023 - - Combined

ADVM

1 minute read

Parsons Awarded $109M Cyber Capabilities Contract

By Happy Mohamed

August 10, 5:10 PM

Parsons Corporation (NYSE:PSN) announced today that the company has been selected by United States Cyber Command (CYBERCOM) to continue support previously provided under the command, control, communications, computers,

PSN

3 minute read

Ameresco Announces Acquisition Of Joint Forces Training Base-Los Alamitos Microgrid Asset; Over 54MW To Be Added To Energy Asset Portfolio; No Financial Terms Disclosed

By Happy Mohamed

August 10, 5:07 PM

Large-scale microgrid project to provide Army and California National Guard with 100% backup power Over 54MW to be added to Energy Asset Portfolio Continues Ameresco's track record of operating solar and

AMRC

2 minute read

Moleculin Provides Update On Ongoing Clinical Trials And Outlines Expected Upcoming Milestones; Multiple Expected Milestones And Interim Data Readouts Expected In 2023

By Happy Mohamed

August 10, 4:59 PM

– Announces successful completion of the Phase 1B portion of its Phase 1B/2 clinical trial Annamycin in combination with Cytarabine for the treatment of AML (MB-106) and opens the Phase 2 portion for

MBRX